Abbvie’s another attempt to get health insurance benefit for ‘Duodopa’
A Parkinson’s disease treatment, ‘Duodopa Intestinal Gel,’ made the second challenge for the health insurance registration.
According to the industry concerned on the 9th, Abbvie’s Duodopa(carbidopa, levodopa) which received judgement of uninsured benefit will be re-introduced at the Health Ins...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
